Skip to main content

HOFSETH BIOCARE ASA – VOTING UNDERTAKINGS SECURED IN RELATION TO PRIVATE PLACEMENT AND B-SHARE AMENDMENTS

Written by Customer Service on . Posted in Public Companies.

Reference is made to the stock exchange announcements from Hofseth BioCare ASA (“HBC” or the “Company“) published on 26 June 2026 and 29 June 2026 regarding a private placement (the “Private Placement“) of new ordinary shares (“Offer Shares“) at a fixed price per share of NOK 1.30 (the “Offer Price“), which raised gross proceeds of approximately NOK 144.5 million.

As described in the referenced stock exchange notices, the Private Placement is divided into two tranches, where the issuance of Offer Shares in the second tranche is subject to approval by an extraordinary general meeting of the Company. Further, as a condition for Hofseth International AS’ participation in the Private Placement, the terms of the Company’s unlisted class B preference shares (the “B-Shares“) shall be amended.

The Company is pleased to inform that is has now secured binding voting undertakings for a sufficient number of shares at the upcoming extraordinary general meeting which secures that the issuance of Offer Shares in the second tranche of the Private Placement and the amendments to the B-Shares will be resolved. The extraordinary general meeting is expected to be held on or about 30 July 2026.

Advisor

Advokatfirmaet CLP DA is acting as legal advisor to the Company.

This information was published by Jon Olav Ødegård, CEO of the Company, on the date and time provided herein.

For further information, please contact:

Jon Olav Ødegård, CEO at HBC
Phone: +47 936 32 966
E-mail: joo@hofsethbiocare.no

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.